Top 10 Medical Stocks To Own Right Now

Check out the companies making headlines before the bell:

BlackBerry – BlackBerry reported adjusted first-quarter profit of 3 cents per share, compared to analysts’ expectations of a breakeven quarter. The software and services company also saw revenue top estimates.

Medtronic – The medical device maker announced a 9 percent increase in its quarterly dividend to 50 cents per share.

United Rentals – The equipment rental company was upgraded to “buy” from “neutral” at UBS, which said cyclical and cost concerns surrounding the company are overdone.

JPMorgan Chase, Bank of America, Citigroup, Wells Fargo – These and other bank stocks are on watch today after 35 of the nation’s largest banks passed the Fed’s latest stress tests. The tests show that the banks have sufficient capital to weather severe adverse conditions.

Top 10 Medical Stocks To Own Right Now: EchoStar Corporation(SATS)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    For the details of CDAM (UK) Ltd’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=CDAM+%28UK%29+Ltd

    These are the top 5 holdings of CDAM (UK) LtdAlphabet Inc (GOOGL) – 57,687 shares, 13.61% of the total portfolio. Shares added by 22.65%Open Text Corp (OTEX) – 1,703,053 shares, 12.52% of the total portfolio. Shares added by 57.24%EchoStar Corp (SATS) – 1,291,355 shares, 11.98% of the total portfolio. Shares added by 32.53%Athene Holding Ltd (ATH) – 1,339,253 shares, 11.64% of the total portfolio. Shares added by 22.45%Hilltop Holdings Inc (HTH) – 2,345,728

  • [By Max Byerly]

    Echostar Co. (NASDAQ:SATS) has received an average rating of “Hold” from the six research firms that are presently covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and one has given a buy rating to the company. The average 1 year price objective among brokerages that have covered the stock in the last year is $73.00.

  • [By Lisa Levin] Companies Reporting Before The Bell
    Nomad Foods Limited (NYSE: NOMD) is estimated to report quarterly earnings at $0.36 per share on revenue of $656.43 million.
    AMC Networks Inc. (NASDAQ: AMCX) is expected to report quarterly earnings at $2.2 per share on revenue of $720.14 million.
    Magna International Inc. (NYSE: MGA) is projected to report quarterly earnings at $1.7 per share on revenue of $10.11 billion.
    Univar Inc. (NYSE: UNVR) is estimated to report quarterly earnings at $0.36 per share on revenue of $2.12 billion.
    Duke Energy Corporation (NYSE: DUK) is expected to report quarterly earnings at $1.14 per share on revenue of $5.78 billion.
    Owens & Minor, Inc. (NYSE: OMI) is projected to report quarterly earnings at $0.47 per share on revenue of $2.40 billion.
    Prestige Brands Holdings, Inc. (NYSE: PBH) is expected to report quarterly earnings at $0.61 per share on revenue of $255.60 million.
    Tribune Media Company (NYSE: TRCO) is projected to report quarterly earnings at $0.06 per share on revenue of $457.67 million.
    ArcBest Corporation (NASDAQ: ARCB) is estimated to report quarterly loss at $0.07 per share on revenue of $691.18 million.
    Genesis Healthcare, Inc. (NYSE: GEN) is projected to report quarterly loss at $0.34 per share on revenue of $1.32 billion.
    Enbridge Inc. (NYSE: ENB) is expected to report quarterly earnings at $0.55 per share on revenue of $10.14 billion.
    Kelly Services, Inc. (NASDAQ: KELYA) is estimated to report quarterly earnings at $0.42 per share on revenue of $1.34 billion.
    NICE Ltd. (NASDAQ: NICE) is expected to report quarterly earnings at $1.01 per share on revenue of $332.93 million.
    World Acceptance Corporation (NASDAQ: WRLD) is estimated to report quarterly earnings at $3.94 per share on revenue of $147.32 million.
    MAXIMUS, Inc. (NYSE: MMS) is expected to report quarterly earnings at $0.84 per share on revenue of $616.04 million.
    Choice Hotels International, Inc. (NYSE: CH
  • [By Max Byerly]

    Teachers Advisors LLC grew its stake in shares of Echostar Co. (NASDAQ:SATS) by 9.2% in the fourth quarter, Holdings Channel reports. The fund owned 59,929 shares of the communications equipment provider’s stock after buying an additional 5,059 shares during the quarter. Teachers Advisors LLC’s holdings in Echostar were worth $3,590,000 at the end of the most recent reporting period.

  • [By Shane Hupp]

    Echostar Holding Corp (NASDAQ:SATS) reached a new 52-week high and low during mid-day trading on Friday . The company traded as low as $51.33 and last traded at $52.44, with a volume of 104714 shares trading hands. The stock had previously closed at $51.79.

Top 10 Medical Stocks To Own Right Now: CRA InternationalInc.(CRAI)

Advisors’ Opinion:

  • [By Joseph Griffin]

    BidaskClub downgraded shares of CRA International (NASDAQ:CRAI) from a strong-buy rating to a buy rating in a research note issued to investors on Saturday morning.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on CRA International (CRAI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on CRA International (CRAI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Medical Stocks To Own Right Now: Navistar International Corporation(NAV)

Advisors’ Opinion:

  • [By Motley Fool Staff]

    Navistar International Corporation (NYSE:NAV)Q2 2018 Earnings Conference CallJune 5, 2018, 9:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Lee Samaha]

    Shares of truck manufacturer PACCAR (NASDAQ:PCAR) rose 14.7% in January, according to data from S&P Global Market Intelligence. It was a strong month for the trucking sector overall, with Navistar (NYSE:NAV), Meritor (NYSE:MTOR), and Dana (NYSE:DAN) all rising more than 20%. The move in January represented another turn in the bear-and-bull debate that’s raged over the trucking sector in the past year.

  • [By Joseph Griffin]

    NavCoin (NAV) is a PoW/PoS coin that uses the X13 hashing algorithm. It launched on June 6th, 2014. NavCoin’s total supply is 62,938,003 coins. The Reddit community for NavCoin is /r/NavCoin and the currency’s Github account can be viewed here. NavCoin’s official Twitter account is @NavCoin. The official website for NavCoin is www.navcoin.org. The official message board for NavCoin is medium.com/nav-coin.

  • [By Shane Hupp]

    NavCoin (CURRENCY:NAV) traded up 17.9% against the dollar during the 1-day period ending at 15:00 PM E.T. on May 20th. Over the last week, NavCoin has traded up 19.5% against the dollar. One NavCoin coin can currently be bought for about $1.28 or 0.00015092 BTC on exchanges including Cryptopia, Binance, Bittrex and cfinex. NavCoin has a total market capitalization of $80.73 million and $13.02 million worth of NavCoin was traded on exchanges in the last day.

  • [By Paul Ausick]

    While the transition period from one chief executive officer to another has barely gotten started at Volkswagen, some big changes may already be afoot. VW’s commercial-vehicles unit, Volkswagen Truck & Bus, is looking at the possibility of buying more shares in U.S. truck maker Navistar International Corp. (NYSE: NAV) or even acquiring the whole company outright.

  • [By Rich Smith]

    Navistar (NYSE:NAV) stock had a tough time of things on Thursday. Posting its fifth-in-a-row earnings beat, Navistar nonetheless missed sales estimates slightly — and investors sold off its stock by 8.5%.

Top 10 Medical Stocks To Own Right Now: CDK Global, Inc.(CDK)

Advisors’ Opinion:

  • [By Max Byerly]

    CDK Global Inc (NASDAQ:CDK) shares hit a new 52-week low during trading on Wednesday after Morgan Stanley lowered their price target on the stock from $75.00 to $68.00. Morgan Stanley currently has an equal weight rating on the stock. CDK Global traded as low as $59.84 and last traded at $60.56, with a volume of 54440 shares changing hands. The stock had previously closed at $60.77.

  • [By Shane Hupp]

    Rikoon Group LLC lifted its stake in shares of CDK Global Inc (NASDAQ:CDK) by 23.1% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 5,873 shares of the software maker’s stock after purchasing an additional 1,102 shares during the quarter. Rikoon Group LLC’s holdings in CDK Global were worth $366,000 at the end of the most recent reporting period.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on CDK Global (CDK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    HMS (NASDAQ: CDK) and CDK Global (NASDAQ:CDK) are both mid-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, dividends, earnings, profitability, valuation, analyst recommendations and institutional ownership.

  • [By Max Byerly]

    CDK Global (NASDAQ:CDK) was upgraded by stock analysts at BidaskClub from a “strong sell” rating to a “sell” rating in a research report issued on Saturday.

  • [By Ethan Ryder]

    Silvercrest Asset Management Group LLC decreased its position in CDK Global Inc (NASDAQ:CDK) by 7.4% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 13,407 shares of the software maker’s stock after selling 1,079 shares during the quarter. Silvercrest Asset Management Group LLC’s holdings in CDK Global were worth $849,000 as of its most recent SEC filing.

Top 10 Medical Stocks To Own Right Now: Cyclacel Pharmaceuticals Inc.(CYCC)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Cyclacel Pharmaceuticals (CYCC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Cyclacel Pharmaceuticals (NASDAQ:CYCC) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “CYCLACEL is a biopharmaceutical company dedicated to the discovery, development and commercialization of novel, mechanism-targeted drugs to treat human cancers and other serious disorders. Three orally-available Cyclacel drugs are in clinical development. Sapacitabine, a cell cycle modulating nucleoside analog, is in Phase 2 studies for the treatment of acute myeloid leukemia in the elderly, myelodysplastic syndromes and cutaneous T-cell lymphoma. Seliciclib (CYC202 or R-roscovitine), a CDK inhibitor, is in Phase 2 for the treatment of lung cancer and nasopharyngeal cancer. “

  • [By Stephan Byrd]

    Investment analysts at Roth Capital assumed coverage on shares of Cyclacel Pharmaceuticals (NASDAQ:CYCC) in a research note issued to investors on Wednesday, The Fly reports. The firm set a “buy” rating and a $8.00 price target on the biotechnology company’s stock. Roth Capital’s price objective would suggest a potential upside of 459.44% from the company’s current price.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Cyclacel Pharmaceuticals (CYCC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Medical Stocks To Own Right Now: Nucor Corporation(NUE)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Shares of Nucor Co. (NYSE:NUE) have been given an average recommendation of “Buy” by the fourteen analysts that are covering the firm, MarketBeat Ratings reports. Five research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. The average 1-year price target among brokers that have covered the stock in the last year is $72.25.

  • [By Neha Chamaria]

    Founded in 1901, United States Steel (NYSE:X) is one of the oldest American companies. Yet, even with more than a century’s experience in steelmaking, U.S. Steel is hugely lagging Nucor (NYSE:NUE) in terms of sales. Nucor and Steel Dynamics (NASDAQ:STLD) have also consistently churned out greater profits from sales than U.S. Steel. While Nucor was founded in 1940, Steel Dynamics started operations only in 1993.

  • [By Jason Hall, Neha Chamaria, and Rich Duprey]

    Three that look particularly appealing today include Best Buy Co Inc (NYSE:BBY), Nucor Corporation (NYSE:NUE), and Starbucks Corporation (NASDAQ:SBUX). Not only do all three pay dividends yielding over 2%, but they also have solid long-term prospects that should lead to growing your capital investment in them in the years ahead. 

  • [By ]

    Cramer and the AAP team note that seven of the companies in their portfolio are reporting this week, including Abbott Laboratories (ABT) , Nucor (NUE) and Honeywell (HON) . Find out what they’re telling their investment club members and get in on the conversation with a free trial subscription to Action Alerts PLUS.

  • [By ]

    In the Lightning Round, Cramer was bullish on GTT Communications (GTT) , Steel Dynamics (STLD) , Nucor (NUE) , Marriott International (MAR) , MGM Resorts (MGM) and Twitter (TWTR) .

  • [By Stephan Byrd]

    Harel Insurance Investments & Financial Services Ltd. reduced its stake in shares of Nucor Co. (NYSE:NUE) by 31.3% in the second quarter, according to its most recent filing with the SEC. The fund owned 2,200 shares of the basic materials company’s stock after selling 1,000 shares during the period. Harel Insurance Investments & Financial Services Ltd.’s holdings in Nucor were worth $138,000 as of its most recent SEC filing.

Top 10 Medical Stocks To Own Right Now: Can-Fite Biopharma Ltd(CANF)

Advisors’ Opinion:

  • [By Shane Hupp]

    Media headlines about Can-Fite Biopharma (NASDAQ:CANF) have trended positive recently, Accern reports. The research firm identifies negative and positive media coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Can-Fite Biopharma earned a media sentiment score of 0.25 on Accern’s scale. Accern also assigned news coverage about the company an impact score of 44.6620747072303 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

  • [By Shane Hupp]

    Press coverage about Can-Fite Biopharma (NASDAQ:CANF) has trended somewhat positive this week, Accern reports. The research group identifies positive and negative news coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Can-Fite Biopharma earned a media sentiment score of 0.24 on Accern’s scale. Accern also gave press coverage about the company an impact score of 45.2576556193403 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) rose 18.2 percent to $4.55 in pre-market trading after the company declared a $0.70 per share special dividend.
    Co-Diagnostics, Inc. (NASDAQ: CODX) rose 11.7 percent to $3.24 in pre-market trading after falling 13.17 percent on Thursday. Co-Diagnostics reported its participation in a research project with the Stanford University.
    Abercrombie & Fitch Co. (NYSE: ANF) shares rose 8.6 percent to $25.95 in pre-market trading after the company posted upbeat Q1 results.
    Zuora, Inc. (NYSE: ZUO) shares rose 8 percent to $23.95 in pre-market trading after the company reported upbeat Q1 earnings and issued strong outlook.
    Lululemon Athletica Inc. (NASDAQ: LULU) shares rose 7.8 percent to $113.25 in pre-market trading after the company reported better-than-expected results for its first quarter. The company also raised its FY18 earnings and sales guidance.
    OPKO Health, Inc. (NYSE: OPK) rose 5.7 percent to $4.10 in pre-market trading.
    Lannett Company, Inc. (NYSE: LCI) rose 5.5 percent to $17.45 in pre-market trading following the FDA approval for Levofloxacin Oral Solution.
    Eversource Energy (NYSE: ES) shares rose 5 percent to $59.8 in pre-market trading.
    VMware, Inc. (NYSE: VMW) rose 4.6 percent to $143.74 in pre-market trading as the company reported stronger-than-expected results for its first quarter on Thursday.
    Energy Transfer Partners, L.P. (NYSE: ETP) rose 4.3 percent to $19.80 in pre-market trading after the company reported the Federal Energy Regulatory Commission approval to place Rover pipeline’s full Mainline B into service.
    T2 Biosystems, Inc. (NASDAQ: TTOO) rose 4.3 percent to $7.73 in pre-market trading after declining 4.26 percent on Thursday.
    Curis, Inc. (NASDAQ: CRIS) rose 4.3 percent to $2.90 in pre-market trading after jumping 21.93 percent on Thursday.
    Sasol Limited (NYSE: SSL) rose 4.2 percent to $37.91 in pre-market trading.
    Nucor Corporatio
  • [By Max Byerly]

    CAN-FITE BIOPHA/S (NYSEAMERICAN:CANF) saw a large drop in short interest in the month of June. As of June 29th, there was short interest totalling 302,241 shares, a drop of 14.1% from the June 15th total of 351,936 shares. Based on an average daily volume of 208,682 shares, the short-interest ratio is presently 1.4 days.

  • [By Lisa Levin] Gainers
    Co-Diagnostics, Inc. (NASDAQ: CODX) jumped 88 percent to $5.4500 after falling 13.17 percent on Thursday. Co-Diagnostics reported its participation in a research project with the Stanford University.
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) climbed 40.3 percent to $5.40 after the company declared a $0.70 per share special dividend.
    Future FinTech Group Inc. (NASDAQ: FTFT) rose 27 percent to $2.73. Future FinTech disclosed a strategic transformation plan including expanding on current blockchain business while also becoming a blockchain incubator, investment and asset management, training, and management consulting.
    SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) gained 14.7 percent to $5.9522 after the company disclosed that its Phase 2b trial of NeuVax in combo with Trastuzumab in HER1+/2+ breast cancer patients met key clinical objectives.
    Lululemon Athletica Inc. (NASDAQ: LULU) shares climbed 14.6 percent to $120.4224 after the company reported better-than-expected results for its first quarter. The company also raised its FY18 earnings and sales guidance.
    FTE Networks, Inc. (NASDAQ: FTNW) gained 10.5 percent to $20.9399.
    T2 Biosystems, Inc. (NASDAQ: TTOO) rose 9 percent to $8.07. Leerink Swann upgraded T2 Biosystems from Market Perform to Outperform.
    Zuora, Inc. (NYSE: ZUO) shares rose 8.3 percent to $24.01 after the company reported upbeat Q1 earnings and issued strong outlook.
    VMware, Inc. (NYSE: VMW) rose 7.7 percent to $148.07 as the company reported stronger-than-expected results for its first quarter on Thursday.
    Ambac Financial Group, Inc. (NASDAQ: AMBC) gained 7.5 percent to $19.91. Ambac Financial will replace Integra Lifesciences Holdings in the S&P SmallCap 600 on Tuesday, June 5.
    Conatus Pharmaceuticals Inc. (NASDAQ: CNAT) gained 7 percent to $4.60.
    Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA) climbed 6.6 percent to $18.23.
    Franklin Street Properties Corp. (NYSE: FSP) gained 5.7 perce

Top 10 Medical Stocks To Own Right Now: Rubicon Technology, Inc.(RBCN)

Advisors’ Opinion:

  • [By Logan Wallace]

    Rubicon Technology (NASDAQ:RBCN) was downgraded by investment analysts at ValuEngine from a “hold” rating to a “sell” rating in a research note issued on Thursday.

  • [By Shane Hupp]

    News coverage about Rubicon Technology (NASDAQ:RBCN) has been trending somewhat positive on Monday, according to Accern Sentiment. The research group identifies positive and negative media coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Rubicon Technology earned a coverage optimism score of 0.22 on Accern’s scale. Accern also assigned media stories about the semiconductor company an impact score of 43.6568126847622 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

Top 10 Medical Stocks To Own Right Now: Gorman-Rupp Company (GRC)

Advisors’ Opinion:

  • [By Stephan Byrd]

    GridCoin (GRC) is a DPoR coin that uses the ProofofResearch hashing algorithm. Its genesis date was November 3rd, 2013. GridCoin’s total supply is 390,312,753 coins. The official message board for GridCoin is cryptocurrencytalk.com/forum/464-gridcoin-grc. The Reddit community for GridCoin is /r/gridcoin and the currency’s Github account can be viewed here. The official website for GridCoin is www.gridcoin.us. GridCoin’s official Twitter account is @GridcoinNetwork and its Facebook page is accessible here.

  • [By Max Byerly]

    GridCoin (GRC) is a DPoR coin that uses the ProofofResearch hashing algorithm. It was first traded on November 3rd, 2013. GridCoin’s total supply is 390,312,753 coins. GridCoin’s official Twitter account is @GridcoinNetwork and its Facebook page is accessible here. The Reddit community for GridCoin is /r/gridcoin and the currency’s Github account can be viewed here. GridCoin’s official message board is cryptocurrencytalk.com/forum/464-gridcoin-grc. GridCoin’s official website is www.gridcoin.us.

  • [By Stephan Byrd]

    Gorman-Rupp Co (NYSE:GRC) Director Christopher H. Lake sold 2,000 shares of the firm’s stock in a transaction on Friday, August 17th. The stock was sold at an average price of $36.69, for a total value of $73,380.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Top 10 Medical Stocks To Own Right Now: Huntington Bancshares Incorporated(HBAN)

Advisors’ Opinion:

  • [By Max Byerly]

    Envestnet Asset Management Inc. lifted its stake in shares of Huntington Bancshares (NASDAQ:HBAN) by 33.7% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 196,941 shares of the bank’s stock after buying an additional 49,653 shares during the quarter. Envestnet Asset Management Inc.’s holdings in Huntington Bancshares were worth $2,972,000 as of its most recent filing with the Securities and Exchange Commission.

  • [By Max Byerly]

    Public Employees Retirement Association of Colorado lessened its stake in shares of Huntington Bancshares (NASDAQ:HBAN) by 4.8% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 197,768 shares of the bank’s stock after selling 10,068 shares during the quarter. Public Employees Retirement Association of Colorado’s holdings in Huntington Bancshares were worth $2,986,000 at the end of the most recent reporting period.

  • [By Max Byerly]

    Here are some of the headlines that may have impacted Accern Sentiment’s rankings:

    Get Huntington Bancshares alerts:

    Active Mover: Huntington Bancshares Incorporated (NASDAQ: HBAN) (alphabetastock.com) P/E Ratio under Consideration – Huntington Bancshares Incorporated (NASDAQ: HBAN) (stocksmarketcap.com) Stocks You Can’t Afford to Pass Up: Huntington Bancshares Incorporated (NASDAQ:HBAN), Under Armour, Inc. (NYSE … (journalfinance.net) Is this stock is Oversold? Huntington Bancshares Incorporated (HBAN) (stockquote.review) Huntington Bancshares Incorporated (NasdaqGS:HBAN) & Eldorado Resorts, Inc. (NasdaqGS:ERI) Valuation at a Glance (parkcitycaller.com)

    Several equities research analysts have issued reports on the company. BidaskClub lowered Huntington Bancshares from a “buy” rating to a “hold” rating in a research note on Wednesday. JPMorgan Chase lifted their price objective on Huntington Bancshares from $16.00 to $17.00 and gave the stock a “neutral” rating in a report on Thursday, January 25th. Zacks Investment Research downgraded Huntington Bancshares from a “buy” rating to a “hold” rating in a report on Thursday, April 5th. BMO Capital Markets reiterated a “hold” rating and issued a $18.00 price objective on shares of Huntington Bancshares in a report on Wednesday, January 24th. Finally, Keefe, Bruyette & Woods reiterated a “hold” rating and issued a $16.75 price objective on shares of Huntington Bancshares in a report on Wednesday, January 24th. Ten investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. The stock currently has a consensus rating of “Buy” and an average target price of $16.98.

  • [By Lee Jackson]

    This smaller cap bank could be an outstanding addition for more aggressive portfolios. Huntington Bancshares Inc. (NASDAQ: HBAN) operates as a holding company for the Huntington National Bank, which provides commercial, small business, consumer and mortgage banking services. Its Retail and Business Banking segment offers financial products and services, including checking accounts, savings accounts, money market accounts, certificates of deposit, consumer loans and small business loans, as well as investments, insurance, interest rate risk protection and foreign exchange and treasury management services.

Leave a Reply

Your email address will not be published. Required fields are marked *